Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rapport Therapeutics (RAPP) Assets Average (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Assets Average data on record, last reported at $505.0 million in Q1 2026.

  • On a quarterly basis, Assets Average rose 63.7% to $505.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $505.0 million, a 63.7% increase, with the full-year FY2025 number at $413.7 million, up 75.9% from a year prior.
  • Assets Average reached $505.0 million in Q1 2026 per RAPP's latest filing, down from $523.9 million in the prior quarter.
  • Over the last five years, Assets Average for RAPP hit a ceiling of $523.9 million in Q4 2025 and a floor of $293.8 million in Q2 2025.
  • A 3-year average of $386.2 million and a median of $338.6 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: grew 21.2% in 2025, then skyrocketed 63.7% in 2026.
  • Tracing RAPP's Assets Average over 3 years: stood at $323.0 million in 2024, then soared by 62.17% to $523.9 million in 2025, then decreased by 3.6% to $505.0 million in 2026.
  • Business Quant data shows Assets Average for RAPP at $505.0 million in Q1 2026, $523.9 million in Q4 2025, and $410.4 million in Q3 2025.